Diagnostic and therapeutic strategies in hyperoxaluria: a plea for early intervention
Open Access
- 1 January 2004
- journal article
- research article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 19 (1), 39-42
- https://doi.org/10.1093/ndt/gfg507
Abstract
Oxalic acid is an end product of human metabolism and does not appear to be needed for any process in the body. Under normal conditions the daily load of oxalate deriving from endogenous production and intestinal absorption is fully excreted by the kidneys. Up to a certain extent renal oxalate excretion may even keep pace with an elevated oxalate load, yet at the expense of hyperoxaluria, a major risk factor for recurrent nephrolithiasis and nephrocalcinosis [1,2]. Unfortunately, hyperoxaluria is all too often overlooked at this stage. The situation becomes far more serious if renal function is impaired (e.g. from complications of hyperoxaluria): the amount of oxalate excreted in the urine will no longer match its production and absorption, resulting in progressive oxalate retention with renal and extrarenal deposition of calcium oxalate, i.e. systemic oxalosis [3]. In a recent survey from the US ∼30% of patients with primary hyperoxaluria (PH) were only diagnosed after having reached end-stage renal failure (ESRF [4]). Late diagnosis is a particular problem in adult patients. In a recent Dutch study, 59% of those patients older than 18 years had already reached ESRF at the time of diagnosis of PH I [5].Keywords
This publication has 24 references indexed in Scilit:
- A United States survey on diagnosis, treatment, and outcome of primary hyperoxaluriaPediatric Nephrology, 2003
- A young patient with end-stage renal disease, dyspnoea, weakness, peripheral neuropathy and an unsuspected underlying diseaseNephrology Dialysis Transplantation, 2003
- Primary hyperoxaluria type 1 in The Netherlands: prevalence and outcomeNephrology Dialysis Transplantation, 2003
- Diagnostic and therapeutic approaches in patients with secondary hyperoxaluriaFrontiers in Bioscience-Landmark, 2003
- Potential mechanisms of marked hyperoxaluria not due to primary hyperoxaluria I or IIKidney International, 2002
- The Primary HyperoxaluriasJournal of the American Society of Nephrology, 2001
- Urinary oxalate excretion in urolithiasis and nephrocalcinosisArchives of Disease in Childhood, 2000
- The gene encoding hydroxypyruvate reductase (GRHPR) is mutated in patients with primary hyperoxaluria type IIHuman Molecular Genetics, 1999
- Urinary oxalate and glycolate excretion in healthy infants and childrenPediatric Nephrology, 1990
- Peroxisomal alanine:glyoxylate aminotransferase deficiency in primary hyperoxaluria type IFEBS Letters, 1986